Paul M Dodson

Summary

Affiliation: Birmingham Heartlands Hospital
Country: UK

Publications

  1. ncbi request reprint Diabetic retinopathy: treatment and prevention
    Paul M Dodson
    Department of Diabetes, England Diabetic Retinopathy Screening Centre of Excellence, Birmingham Heartlands Hospital, Birmingham, UK
    Diab Vasc Dis Res 4:S9-S11. 2007
  2. ncbi request reprint PKC inhibition and diabetic microvascular complications
    Margaret Clarke
    Department of Diabetes, and the Diabetic Retinopathy Screening Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, UK
    Best Pract Res Clin Endocrinol Metab 21:573-86. 2007
  3. doi request reprint Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    P M Dodson
    Life and Health Sciences, Aston University, Birmingham, UK
    Eye (Lond) 23:997-1003. 2009

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Diabetic retinopathy: treatment and prevention
    Paul M Dodson
    Department of Diabetes, England Diabetic Retinopathy Screening Centre of Excellence, Birmingham Heartlands Hospital, Birmingham, UK
    Diab Vasc Dis Res 4:S9-S11. 2007
    ..These promising data justify further evaluation of the mechanism and role of fenofibrate, in addition to standard therapy, in the management of diabetic retinopathy...
  2. ncbi request reprint PKC inhibition and diabetic microvascular complications
    Margaret Clarke
    Department of Diabetes, and the Diabetic Retinopathy Screening Centre, Heart of England NHS Foundation Trust, Bordesley Green East, Birmingham B9 5SS, UK
    Best Pract Res Clin Endocrinol Metab 21:573-86. 2007
    ..There have been no significant concerns over safety or the side-effects profile in the clinical trials. Ruboxistaurin currently has approvable status pending further randomized trials defined by the US Food and Drug Administration (FDA)...
  3. doi request reprint Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    P M Dodson
    Life and Health Sciences, Aston University, Birmingham, UK
    Eye (Lond) 23:997-1003. 2009
    ..In addition, elucidation of the mechanism(s) of effect of fenofibrate is indicated...